The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Human Coronavirus Nucleoprotein Market Research Report 2025
Synopsis
The human coronavirus nucleoprotein (N protein) is a crucial component of the coronavirus virion (virus particle). Coronaviruses are a family of viruses that can cause respiratory illnesses in humans and animals.
The global Human Coronavirus Nucleoprotein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Coronavirus Nucleoprotein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Coronavirus Nucleoprotein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Coronavirus Nucleoprotein include Abcam, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, Merck KGaA (Sigma-Aldrich), Seebio, Elabscience and Novus Biologicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Coronavirus Nucleoprotein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coronavirus Nucleoprotein.
Report Scope
The Human Coronavirus Nucleoprotein market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coronavirus Nucleoprotein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coronavirus Nucleoprotein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
The Native Antigen Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Agrisera
Merck KGaA (Sigma-Aldrich)
Seebio
Elabscience
Novus Biologicals
Sinobiological
Eagle Biosciences
BiosPacific
Segment by Type
90%≤Purity≤95%
Purity＞95%
Other
Segment by Application
RDT & ELISA
Vaccine Development
Antiviral Drugs
Research
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Coronavirus Nucleoprotein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Coronavirus Nucleoprotein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The human coronavirus nucleoprotein (N protein) is a crucial component of the coronavirus virion (virus particle). Coronaviruses are a family of viruses that can cause respiratory illnesses in humans and animals.
The global Human Coronavirus Nucleoprotein market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Coronavirus Nucleoprotein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Coronavirus Nucleoprotein is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Coronavirus Nucleoprotein include Abcam, The Native Antigen Company, Bio-Rad Laboratories, Thermo Fisher Scientific, Agrisera, Merck KGaA (Sigma-Aldrich), Seebio, Elabscience and Novus Biologicals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Coronavirus Nucleoprotein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Coronavirus Nucleoprotein.
Report Scope
The Human Coronavirus Nucleoprotein market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Coronavirus Nucleoprotein market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Coronavirus Nucleoprotein manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abcam
The Native Antigen Company
Bio-Rad Laboratories
Thermo Fisher Scientific
Agrisera
Merck KGaA (Sigma-Aldrich)
Seebio
Elabscience
Novus Biologicals
Sinobiological
Eagle Biosciences
BiosPacific
Segment by Type
90%≤Purity≤95%
Purity＞95%
Other
Segment by Application
RDT & ELISA
Vaccine Development
Antiviral Drugs
Research
Other
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Coronavirus Nucleoprotein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Coronavirus Nucleoprotein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Human Coronavirus Nucleoprotein Market Overview
1.1 Product Overview and Scope of Human Coronavirus Nucleoprotein
1.2 Human Coronavirus Nucleoprotein Segment by Type
1.2.1 Global Human Coronavirus Nucleoprotein Market Value Comparison by Type (2024-2030)
1.2.2 90%≤Purity≤95%
1.2.3 Purity＞95%
1.2.4 Other
1.3 Human Coronavirus Nucleoprotein Segment by Application
1.3.1 Global Human Coronavirus Nucleoprotein Market Value by Application: (2024-2030)
1.3.2 RDT & ELISA
1.3.3 Vaccine Development
1.3.4 Antiviral Drugs
1.3.5 Research
1.3.6 Other
1.4 Global Human Coronavirus Nucleoprotein Market Size Estimates and Forecasts
1.4.1 Global Human Coronavirus Nucleoprotein Revenue 2019-2030
1.4.2 Global Human Coronavirus Nucleoprotein Sales 2019-2030
1.4.3 Global Human Coronavirus Nucleoprotein Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Coronavirus Nucleoprotein Market Competition by Manufacturers
2.1 Global Human Coronavirus Nucleoprotein Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Coronavirus Nucleoprotein Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Coronavirus Nucleoprotein Average Price by Manufacturers (2019-2024)
2.4 Global Human Coronavirus Nucleoprotein Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Coronavirus Nucleoprotein, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Coronavirus Nucleoprotein, Product Type & Application
2.7 Human Coronavirus Nucleoprotein Market Competitive Situation and Trends
2.7.1 Human Coronavirus Nucleoprotein Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Coronavirus Nucleoprotein Players Market Share by Revenue
2.7.3 Global Human Coronavirus Nucleoprotein Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Coronavirus Nucleoprotein Retrospective Market Scenario by Region
3.1 Global Human Coronavirus Nucleoprotein Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Coronavirus Nucleoprotein Global Human Coronavirus Nucleoprotein Sales by Region: 2019-2030
3.2.1 Global Human Coronavirus Nucleoprotein Sales by Region: 2019-2024
3.2.2 Global Human Coronavirus Nucleoprotein Sales by Region: 2025-2030
3.3 Global Human Coronavirus Nucleoprotein Global Human Coronavirus Nucleoprotein Revenue by Region: 2019-2030
3.3.1 Global Human Coronavirus Nucleoprotein Revenue by Region: 2019-2024
3.3.2 Global Human Coronavirus Nucleoprotein Revenue by Region: 2025-2030
3.4 North America Human Coronavirus Nucleoprotein Market Facts & Figures by Country
3.4.1 North America Human Coronavirus Nucleoprotein Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Coronavirus Nucleoprotein Sales by Country (2019-2030)
3.4.3 North America Human Coronavirus Nucleoprotein Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Human Coronavirus Nucleoprotein Market Facts & Figures by Country
3.5.1 Europe Human Coronavirus Nucleoprotein Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Coronavirus Nucleoprotein Sales by Country (2019-2030)
3.5.3 Europe Human Coronavirus Nucleoprotein Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Coronavirus Nucleoprotein Market Facts & Figures by Country
3.6.1 Asia Pacific Human Coronavirus Nucleoprotein Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Coronavirus Nucleoprotein Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Coronavirus Nucleoprotein Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Human Coronavirus Nucleoprotein Market Facts & Figures by Country
3.7.1 Latin America Human Coronavirus Nucleoprotein Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Coronavirus Nucleoprotein Sales by Country (2019-2030)
3.7.3 Latin America Human Coronavirus Nucleoprotein Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Coronavirus Nucleoprotein Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Coronavirus Nucleoprotein Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Coronavirus Nucleoprotein Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Coronavirus Nucleoprotein Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Human Coronavirus Nucleoprotein Sales by Type (2019-2030)
4.1.1 Global Human Coronavirus Nucleoprotein Sales by Type (2019-2024)
4.1.2 Global Human Coronavirus Nucleoprotein Sales by Type (2025-2030)
4.1.3 Global Human Coronavirus Nucleoprotein Sales Market Share by Type (2019-2030)
4.2 Global Human Coronavirus Nucleoprotein Revenue by Type (2019-2030)
4.2.1 Global Human Coronavirus Nucleoprotein Revenue by Type (2019-2024)
4.2.2 Global Human Coronavirus Nucleoprotein Revenue by Type (2025-2030)
4.2.3 Global Human Coronavirus Nucleoprotein Revenue Market Share by Type (2019-2030)
4.3 Global Human Coronavirus Nucleoprotein Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Coronavirus Nucleoprotein Sales by Application (2019-2030)
5.1.1 Global Human Coronavirus Nucleoprotein Sales by Application (2019-2024)
5.1.2 Global Human Coronavirus Nucleoprotein Sales by Application (2025-2030)
5.1.3 Global Human Coronavirus Nucleoprotein Sales Market Share by Application (2019-2030)
5.2 Global Human Coronavirus Nucleoprotein Revenue by Application (2019-2030)
5.2.1 Global Human Coronavirus Nucleoprotein Revenue by Application (2019-2024)
5.2.2 Global Human Coronavirus Nucleoprotein Revenue by Application (2025-2030)
5.2.3 Global Human Coronavirus Nucleoprotein Revenue Market Share by Application (2019-2030)
5.3 Global Human Coronavirus Nucleoprotein Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abcam
6.1.1 Abcam Corporation Information
6.1.2 Abcam Description and Business Overview
6.1.3 Abcam Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abcam Human Coronavirus Nucleoprotein Product Portfolio
6.1.5 Abcam Recent Developments/Updates
6.2 The Native Antigen Company
6.2.1 The Native Antigen Company Corporation Information
6.2.2 The Native Antigen Company Description and Business Overview
6.2.3 The Native Antigen Company Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.2.4 The Native Antigen Company Human Coronavirus Nucleoprotein Product Portfolio
6.2.5 The Native Antigen Company Recent Developments/Updates
6.3 Bio-Rad Laboratories
6.3.1 Bio-Rad Laboratories Corporation Information
6.3.2 Bio-Rad Laboratories Description and Business Overview
6.3.3 Bio-Rad Laboratories Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bio-Rad Laboratories Human Coronavirus Nucleoprotein Product Portfolio
6.3.5 Bio-Rad Laboratories Recent Developments/Updates
6.4 Thermo Fisher Scientific
6.4.1 Thermo Fisher Scientific Corporation Information
6.4.2 Thermo Fisher Scientific Description and Business Overview
6.4.3 Thermo Fisher Scientific Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Thermo Fisher Scientific Human Coronavirus Nucleoprotein Product Portfolio
6.4.5 Thermo Fisher Scientific Recent Developments/Updates
6.5 Agrisera
6.5.1 Agrisera Corporation Information
6.5.2 Agrisera Description and Business Overview
6.5.3 Agrisera Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Agrisera Human Coronavirus Nucleoprotein Product Portfolio
6.5.5 Agrisera Recent Developments/Updates
6.6 Merck KGaA (Sigma-Aldrich)
6.6.1 Merck KGaA (Sigma-Aldrich) Corporation Information
6.6.2 Merck KGaA (Sigma-Aldrich) Description and Business Overview
6.6.3 Merck KGaA (Sigma-Aldrich) Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Merck KGaA (Sigma-Aldrich) Human Coronavirus Nucleoprotein Product Portfolio
6.6.5 Merck KGaA (Sigma-Aldrich) Recent Developments/Updates
6.7 Seebio
6.6.1 Seebio Corporation Information
6.6.2 Seebio Description and Business Overview
6.6.3 Seebio Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Seebio Human Coronavirus Nucleoprotein Product Portfolio
6.7.5 Seebio Recent Developments/Updates
6.8 Elabscience
6.8.1 Elabscience Corporation Information
6.8.2 Elabscience Description and Business Overview
6.8.3 Elabscience Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Elabscience Human Coronavirus Nucleoprotein Product Portfolio
6.8.5 Elabscience Recent Developments/Updates
6.9 Novus Biologicals
6.9.1 Novus Biologicals Corporation Information
6.9.2 Novus Biologicals Description and Business Overview
6.9.3 Novus Biologicals Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Novus Biologicals Human Coronavirus Nucleoprotein Product Portfolio
6.9.5 Novus Biologicals Recent Developments/Updates
6.10 Sinobiological
6.10.1 Sinobiological Corporation Information
6.10.2 Sinobiological Description and Business Overview
6.10.3 Sinobiological Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Sinobiological Human Coronavirus Nucleoprotein Product Portfolio
6.10.5 Sinobiological Recent Developments/Updates
6.11 Eagle Biosciences
6.11.1 Eagle Biosciences Corporation Information
6.11.2 Eagle Biosciences Human Coronavirus Nucleoprotein Description and Business Overview
6.11.3 Eagle Biosciences Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Eagle Biosciences Human Coronavirus Nucleoprotein Product Portfolio
6.11.5 Eagle Biosciences Recent Developments/Updates
6.12 BiosPacific
6.12.1 BiosPacific Corporation Information
6.12.2 BiosPacific Human Coronavirus Nucleoprotein Description and Business Overview
6.12.3 BiosPacific Human Coronavirus Nucleoprotein Sales, Revenue and Gross Margin (2019-2024)
6.12.4 BiosPacific Human Coronavirus Nucleoprotein Product Portfolio
6.12.5 BiosPacific Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Coronavirus Nucleoprotein Industry Chain Analysis
7.2 Human Coronavirus Nucleoprotein Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Coronavirus Nucleoprotein Production Mode & Process
7.4 Human Coronavirus Nucleoprotein Sales and Marketing
7.4.1 Human Coronavirus Nucleoprotein Sales Channels
7.4.2 Human Coronavirus Nucleoprotein Distributors
7.5 Human Coronavirus Nucleoprotein Customers
8 Human Coronavirus Nucleoprotein Market Dynamics
8.1 Human Coronavirus Nucleoprotein Industry Trends
8.2 Human Coronavirus Nucleoprotein Market Drivers
8.3 Human Coronavirus Nucleoprotein Market Challenges
8.4 Human Coronavirus Nucleoprotein Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Human Coronavirus Nucleoprotein Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Human Coronavirus Nucleoprotein Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Human Coronavirus Nucleoprotein Market Competitive Situation by Manufacturers in 2023
Table 4. Global Human Coronavirus Nucleoprotein Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Human Coronavirus Nucleoprotein Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Human Coronavirus Nucleoprotein Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Human Coronavirus Nucleoprotein Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Human Coronavirus Nucleoprotein, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Human Coronavirus Nucleoprotein, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Coronavirus Nucleoprotein, Product Type & Application
Table 12. Global Key Manufacturers of Human Coronavirus Nucleoprotein, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Coronavirus Nucleoprotein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Coronavirus Nucleoprotein as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Coronavirus Nucleoprotein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Human Coronavirus Nucleoprotein Sales by Region (2019-2024) & (K Units)
Table 18. Global Human Coronavirus Nucleoprotein Sales Market Share by Region (2019-2024)
Table 19. Global Human Coronavirus Nucleoprotein Sales by Region (2025-2030) & (K Units)
Table 20. Global Human Coronavirus Nucleoprotein Sales Market Share by Region (2025-2030)
Table 21. Global Human Coronavirus Nucleoprotein Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Human Coronavirus Nucleoprotein Revenue Market Share by Region (2019-2024)
Table 23. Global Human Coronavirus Nucleoprotein Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Human Coronavirus Nucleoprotein Revenue Market Share by Region (2025-2030)
Table 25. North America Human Coronavirus Nucleoprotein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Human Coronavirus Nucleoprotein Sales by Country (2019-2024) & (K Units)
Table 27. North America Human Coronavirus Nucleoprotein Sales by Country (2025-2030) & (K Units)
Table 28. North America Human Coronavirus Nucleoprotein Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Human Coronavirus Nucleoprotein Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Human Coronavirus Nucleoprotein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Human Coronavirus Nucleoprotein Sales by Country (2019-2024) & (K Units)
Table 32. Europe Human Coronavirus Nucleoprotein Sales by Country (2025-2030) & (K Units)
Table 33. Europe Human Coronavirus Nucleoprotein Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Human Coronavirus Nucleoprotein Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Human Coronavirus Nucleoprotein Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Human Coronavirus Nucleoprotein Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Human Coronavirus Nucleoprotein Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Human Coronavirus Nucleoprotein Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Human Coronavirus Nucleoprotein Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Human Coronavirus Nucleoprotein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Human Coronavirus Nucleoprotein Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Human Coronavirus Nucleoprotein Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Human Coronavirus Nucleoprotein Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Human Coronavirus Nucleoprotein Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Human Coronavirus Nucleoprotein Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Human Coronavirus Nucleoprotein Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Human Coronavirus Nucleoprotein Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Human Coronavirus Nucleoprotein Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Human Coronavirus Nucleoprotein Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Human Coronavirus Nucleoprotein Sales (K Units) by Type (2019-2024)
Table 51. Global Human Coronavirus Nucleoprotein Sales (K Units) by Type (2025-2030)
Table 52. Global Human Coronavirus Nucleoprotein Sales Market Share by Type (2019-2024)
Table 53. Global Human Coronavirus Nucleoprotein Sales Market Share by Type (2025-2030)
Table 54. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Human Coronavirus Nucleoprotein Revenue Market Share by Type (2019-2024)
Table 57. Global Human Coronavirus Nucleoprotein Revenue Market Share by Type (2025-2030)
Table 58. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Type (2019-2024)
Table 59. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Type (2025-2030)
Table 60. Global Human Coronavirus Nucleoprotein Sales (K Units) by Application (2019-2024)
Table 61. Global Human Coronavirus Nucleoprotein Sales (K Units) by Application (2025-2030)
Table 62. Global Human Coronavirus Nucleoprotein Sales Market Share by Application (2019-2024)
Table 63. Global Human Coronavirus Nucleoprotein Sales Market Share by Application (2025-2030)
Table 64. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Human Coronavirus Nucleoprotein Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Human Coronavirus Nucleoprotein Revenue Market Share by Application (2019-2024)
Table 67. Global Human Coronavirus Nucleoprotein Revenue Market Share by Application (2025-2030)
Table 68. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Application (2019-2024)
Table 69. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Application (2025-2030)
Table 70. Abcam Corporation Information
Table 71. Abcam Description and Business Overview
Table 72. Abcam Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Abcam Human Coronavirus Nucleoprotein Product
Table 74. Abcam Recent Developments/Updates
Table 75. The Native Antigen Company Corporation Information
Table 76. The Native Antigen Company Description and Business Overview
Table 77. The Native Antigen Company Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. The Native Antigen Company Human Coronavirus Nucleoprotein Product
Table 79. The Native Antigen Company Recent Developments/Updates
Table 80. Bio-Rad Laboratories Corporation Information
Table 81. Bio-Rad Laboratories Description and Business Overview
Table 82. Bio-Rad Laboratories Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bio-Rad Laboratories Human Coronavirus Nucleoprotein Product
Table 84. Bio-Rad Laboratories Recent Developments/Updates
Table 85. Thermo Fisher Scientific Corporation Information
Table 86. Thermo Fisher Scientific Description and Business Overview
Table 87. Thermo Fisher Scientific Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Thermo Fisher Scientific Human Coronavirus Nucleoprotein Product
Table 89. Thermo Fisher Scientific Recent Developments/Updates
Table 90. Agrisera Corporation Information
Table 91. Agrisera Description and Business Overview
Table 92. Agrisera Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Agrisera Human Coronavirus Nucleoprotein Product
Table 94. Agrisera Recent Developments/Updates
Table 95. Merck KGaA (Sigma-Aldrich) Corporation Information
Table 96. Merck KGaA (Sigma-Aldrich) Description and Business Overview
Table 97. Merck KGaA (Sigma-Aldrich) Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Merck KGaA (Sigma-Aldrich) Human Coronavirus Nucleoprotein Product
Table 99. Merck KGaA (Sigma-Aldrich) Recent Developments/Updates
Table 100. Seebio Corporation Information
Table 101. Seebio Description and Business Overview
Table 102. Seebio Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Seebio Human Coronavirus Nucleoprotein Product
Table 104. Seebio Recent Developments/Updates
Table 105. Elabscience Corporation Information
Table 106. Elabscience Description and Business Overview
Table 107. Elabscience Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Elabscience Human Coronavirus Nucleoprotein Product
Table 109. Elabscience Recent Developments/Updates
Table 110. Novus Biologicals Corporation Information
Table 111. Novus Biologicals Description and Business Overview
Table 112. Novus Biologicals Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Novus Biologicals Human Coronavirus Nucleoprotein Product
Table 114. Novus Biologicals Recent Developments/Updates
Table 115. Sinobiological Corporation Information
Table 116. Sinobiological Description and Business Overview
Table 117. Sinobiological Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Sinobiological Human Coronavirus Nucleoprotein Product
Table 119. Sinobiological Recent Developments/Updates
Table 120. Eagle Biosciences Corporation Information
Table 121. Eagle Biosciences Description and Business Overview
Table 122. Eagle Biosciences Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Eagle Biosciences Human Coronavirus Nucleoprotein Product
Table 124. Eagle Biosciences Recent Developments/Updates
Table 125. BiosPacific Corporation Information
Table 126. BiosPacific Description and Business Overview
Table 127. BiosPacific Human Coronavirus Nucleoprotein Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. BiosPacific Human Coronavirus Nucleoprotein Product
Table 129. BiosPacific Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Human Coronavirus Nucleoprotein Distributors List
Table 133. Human Coronavirus Nucleoprotein Customers List
Table 134. Human Coronavirus Nucleoprotein Market Trends
Table 135. Human Coronavirus Nucleoprotein Market Drivers
Table 136. Human Coronavirus Nucleoprotein Market Challenges
Table 137. Human Coronavirus Nucleoprotein Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Coronavirus Nucleoprotein
Figure 2. Global Human Coronavirus Nucleoprotein Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Human Coronavirus Nucleoprotein Market Share by Type in 2023 & 2030
Figure 4. 90%≤Purity≤95% Product Picture
Figure 5. Purity＞95% Product Picture
Figure 6. Other Product Picture
Figure 7. Global Human Coronavirus Nucleoprotein Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Human Coronavirus Nucleoprotein Market Share by Application in 2023 & 2030
Figure 9. RDT & ELISA
Figure 10. Vaccine Development
Figure 11. Antiviral Drugs
Figure 12. Research
Figure 13. Other
Figure 14. Global Human Coronavirus Nucleoprotein Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Human Coronavirus Nucleoprotein Market Size (2019-2030) & (US$ Million)
Figure 16. Global Human Coronavirus Nucleoprotein Sales (2019-2030) & (K Units)
Figure 17. Global Human Coronavirus Nucleoprotein Average Price (US$/Unit) & (2019-2030)
Figure 18. Human Coronavirus Nucleoprotein Report Years Considered
Figure 19. Human Coronavirus Nucleoprotein Sales Share by Manufacturers in 2023
Figure 20. Global Human Coronavirus Nucleoprotein Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Human Coronavirus Nucleoprotein Players: Market Share by Revenue in 2023
Figure 22. Human Coronavirus Nucleoprotein Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Human Coronavirus Nucleoprotein Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Human Coronavirus Nucleoprotein Sales Market Share by Country (2019-2030)
Figure 25. North America Human Coronavirus Nucleoprotein Revenue Market Share by Country (2019-2030)
Figure 26. United States Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Human Coronavirus Nucleoprotein Sales Market Share by Country (2019-2030)
Figure 29. Europe Human Coronavirus Nucleoprotein Revenue Market Share by Country (2019-2030)
Figure 30. Germany Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Russia Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Human Coronavirus Nucleoprotein Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Human Coronavirus Nucleoprotein Revenue Market Share by Region (2019-2030)
Figure 37. China Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Australia Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Southeast Asia Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Human Coronavirus Nucleoprotein Sales Market Share by Country (2019-2030)
Figure 45. Latin America Human Coronavirus Nucleoprotein Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Human Coronavirus Nucleoprotein Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Human Coronavirus Nucleoprotein Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Human Coronavirus Nucleoprotein Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Human Coronavirus Nucleoprotein by Type (2019-2030)
Figure 55. Global Revenue Market Share of Human Coronavirus Nucleoprotein by Type (2019-2030)
Figure 56. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Human Coronavirus Nucleoprotein by Application (2019-2030)
Figure 58. Global Revenue Market Share of Human Coronavirus Nucleoprotein by Application (2019-2030)
Figure 59. Global Human Coronavirus Nucleoprotein Price (US$/Unit) by Application (2019-2030)
Figure 60. Human Coronavirus Nucleoprotein Value Chain
Figure 61. Human Coronavirus Nucleoprotein Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
